Champions Oncology Inc
NASDAQ:CSBR

Watchlist Manager
Champions Oncology Inc Logo
Champions Oncology Inc
NASDAQ:CSBR
Watchlist
Price: 7.505 USD -0.6% Market Closed
Market Cap: 102m USD
Have any thoughts about
Champions Oncology Inc?
Write Note

Operating Margin
Champions Oncology Inc

-1.5%
Current
-6%
Average
3.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1.5%
=
Operating Profit
-787k
/
Revenue
53.6m

Operating Margin Across Competitors

Country US
Market Cap 102.8m USD
Operating Margin
-1%
Country US
Market Cap 1.2T USD
Operating Margin
14%
Country US
Market Cap 200.4B USD
Operating Margin
17%
Country US
Market Cap 165.1B USD
Operating Margin
21%
Country KR
Market Cap 67.4T KRW
Operating Margin
31%
Country CH
Market Cap 38.3B CHF
Operating Margin
13%
Country US
Market Cap 38.4B USD
Operating Margin
24%
Country US
Market Cap 35.8B USD
Operating Margin
14%
Country US
Market Cap 26.7B USD
Operating Margin
28%
Country US
Market Cap 24B USD
Operating Margin
20%
Country CN
Market Cap 163.2B CNY
Operating Margin
27%
No Stocks Found

Champions Oncology Inc
Glance View

Market Cap
102.8m USD
Industry
Life Sciences Tools & Services

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Baltimore, Maryland and currently employs 194 full-time employees. This technology includes the Company’s in-vivo, ex-vivo and biomarker platforms, oncology software solutions, and computational-based discovery platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology. The Company’s software as a service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. The Company’s drug discovery and development business leverages the computational and experimental capabilities within its platforms. Their discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify novel therapeutic targets.

CSBR Intrinsic Value
7.1 USD
Overvaluation 5%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1.5%
=
Operating Profit
-787k
/
Revenue
53.6m
What is the Operating Margin of Champions Oncology Inc?

Based on Champions Oncology Inc's most recent financial statements, the company has Operating Margin of -1.5%.